Physician profile
Mina H Iskander
NPI 1639584832
$41,332.95
in general payments reported to CMS, 2019-2025
21 companies · $7,050 in 2025
The $7,050 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,213 · 2020: $1,584 · 2021: $11K · 2022: $11K · 2023: $3,742 · 2024: $4,916 · 2025: $7,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $9,641 · Food and Beverage: $5,929 · Gift: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $9,640.59 |
| Food and Beverage | $5,929.46 |
| Gift | $137.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $18,195.67 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abbott Laboratories | $8,829.96 | 2019-2025 | Optis, Triclip, Amplatzer Amulet |
| Edwards Lifesciences Corporation | $4,179.18 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $3,410.91 | 2019-2025 | Rotablator Rotational Atherectomy System Console Kit, Watchman Access System |
| Medtronic Vascular, INC. | $2,902.21 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $1,606.95 | 2022-2025 | Gore Cardioform Septal Occluder |
| Abiomed | $899.72 | 2019-2025 | Impella |
| Cardiva Medical, INC. | $220.68 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $218.95 | 2019 | |
| Opsens INC. | $178.47 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $125.25 | 2019 | |
| Amgen INC. | $117.14 | 2019 | |
| Janssen Pharmaceuticals, INC | $111.32 | 2020 | |
| Shockwave Medical, INC | $111.29 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $102.89 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $26.87 | 2024 | Farxiga |
| Terumo Medical Corporation | $25.23 | 2020 | |
| Novo Nordisk INC | $23.28 | 2024 | Ozempic |
| Heartflow, INC. | $22.56 | 2024 | |
| Teleflex LLC | $15.70 | 2025 | Manta |
| Penumbra, INC. | $8.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Iskander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.